Navigation Links
CASI Pharmaceuticals Reports Second Quarter 2014 Financial Results
Date:8/14/2014

2013Total revenues

$
-

$
-
Research and development

$
724,493

$
836,582
General and administrative

$
891,917

$   1,015,701Net loss

$ (1,616,410)

$   (1,851,840)Net loss per share attributable to

common shareholders (basic and diluted)

 

$
(0.06)

$
(0.07)
Weighted average number of

shares outstanding (basic and diluted)

 

27,040,429

 

27,023,038Cash and cash equivalents

$13,079,745

$17,222,918 Six Months Ended June 30,2014

2013Total revenues

$
-

$
-
Research and development

$
,284,467

$
,342,957
General and administrative

$
,783,292

$   1,645,603Net loss

$ (3,067,759)

$   (2,987,727)Net loss per share attributable to

common shareholders (basic and diluted)

 

$
(0.11)

 

$
(0.12)
Weighted average number of

shares outsta
'/>"/>

SOURCE CASI Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
2. Imprimis Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Operational Update
3. Dipexium Pharmaceuticals Reports Second Quarter 2014 Financial and Operational Results
4. Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
5. Rock Creek Pharmaceuticals Reports Second Quarter and Announces Clinical Update
6. AcelRx Pharmaceuticals Reports Second Quarter 2014 Financial Results
7. Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results
8. Absorption Pharmaceuticals CEO Jeff Abraham Discusses Promescent on KFI
9. Global Diabetic Neuropathy Market 2014-2018: Key Vendors are Eli Lilly and Co, Janssen Pharmaceuticals and Pfizer Inc.
10. Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes
11. AcelRx Pharmaceuticals to Participate in Three Upcoming Investor Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015 China Biologic Products, Inc. ... leading fully integrated plasma-based biopharmaceutical company in ... Company,s subsidiary Guizhou Taibang Biological Products Co., Ltd. ... (the "Agreement") with Xinjiang Deyuan Bioengineering Co., Ltd. ... allows Guizhou Taibang to source no less than ...
(Date:9/2/2015)... , Sept. 2, 2015 Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced today ... at both the FBR Second Annual Healthcare Conference and ... follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor meetings ...
(Date:9/2/2015)... , Sept. 2, 2015  Kastle Therapeutics (Kastle), ... commercializing pharmaceuticals for diseases with high unmet medical ... executives to key commercial operating positions. ... President, Commercial; Sean was previously Global Marketing Director ... appointed as Director, Commercial Strategy and Analytics; Nick ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3
...  ChromaDex® Corporation (OTCBB: CDXC), an innovative natural products ... to the dietary supplement, food & beverage, cosmetic ... and unit sales of its recently launched ... the Company,s initial forecast and expectations during the ...
... May 16, 2012  Inrad Optics, Inc. (OTCBB: INRD) has released its ... 2012. Revenues for the first quarter were ... period last year. Orders for the first three ... Order backlog increased to $5.2 million for the three months ...
Cached Medicine Technology:ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 2ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 3ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 4ChromaDex® Experiencing Higher Than Expected Demand For Its Recently Launched BluScience™ Line of Dietary Supplements 5Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 2Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 3Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 4Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 5Inrad Optics, Inc. Announces Financial Results For First Quarter 2012 6
(Date:9/2/2015)... ... September 02, 2015 , ... ... content, records and case management solutions and services to both government and commercial ... Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC ...
(Date:9/2/2015)... ... September 02, 2015 , ... Available ... marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution ... biotechnological anti-aging power with a lipid-replenishing marine oil for intense nourishing and moisturizing. ...
(Date:9/2/2015)... ... September 02, 2015 , ... Dr. Robert G. Schwartz , ... now certified in “Systema”: a Russian martial art system that is also a philosophy ... Systema , which dates back to the 10th century, is a Russian Martial ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... plastic surgeries conducted each year on teenagers, quoting a New York City-area plastic ... Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients ...
(Date:9/1/2015)... ... September 02, 2015 , ... The Journal of Pain Research ... in the USA ”. , As corresponding author Mr Christopher Malone says “Migraine headache ... our study, we endeavoured to better understand how migraine headaches impact the lives of ...
Breaking Medicine News(10 mins):Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2
... France June 04, 2009 The cause of ... after Alzheimer,s disease, is unknown, but in most cases ... risk factors and genetic susceptibility. Laboratory studies in rats ... an animal model of PD and several epidemiological studies ...
... BioTrends Research Group, Inc. announces the release of the baseline ... The survey was completed by U.S. Rheumatologists in May 2009, ... , Once monthly dosing seems to be playing well, according ... of SIMPONI. 84% of the Rheumatologists surveyed report that they ...
... Pa., June 4 Herley Industries, Inc. (Nasdaq: ... Israel, has recently received contracts valued at approximately $4 million ... customer. These are follow-on awards for an existing customer ... to a U.S. aircraft. , , Herley Industries, Inc. ...
... The Cardiovascular Nurse and Technologist Symposium at TCT 2009 ... clinical/administrative strategies for the management of the cardiovascular patient: ... receiving PCI, Revascularization decisions, Management decisions regarding patients with ... charge of your own health WHEN: ...
... uninterrupted supply for customers , , LAKE ZURICH, Ill., ... improving blood collection, safety and availability for patient care, said ... a patent lawsuit brought by Haemonetics Corporation in 2005. ... , , In conjunction with this litigation, ...
... , For Father,s Day, Forget The Usual With A Gift ... Physician Formulated Anti-Wrinkle Moisturizer , , PACIFIC PALISADES, Calif., ... This year, give Dad something he secretly desires but may ... the best for the family hero. Dermagenics Physician-Formulated ...
Cached Medicine News:Health News:Association found between Parkinson's disease and pesticide exposure in French farm workers 2Health News:Once Monthly Dosing: How Much of a Competitive Advantage is it? Rheumatologists Provide Insight in the Baseline Report of LaunchTrends(TM): SIMPONI(TM) 2Health News:Herley's Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer 2Health News:Nurses: Providing angioplasty patient care in and out of the cath lab 2Health News:Fenwal Statement Regarding Patent Litigation 2Health News:SHOW DAD YOU LOVE HIS FACE 2
... The VersaPulse PowerSuite holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... Nd:YAG technology has allowed for perfecting mini-invasive ... of various pathologies with a considerable social ... for reducing the post-operatory times and represents ... costs in all hospital structures.,DEKAs family of ...
... have to choose. The Apogee Elite ... 755nm Alexandrite laser and a high ... in one convenient unit. The ... for hair removal, pigmented lesions, facial ...
Single use trocar with non-conductive sleeves for gaining and maintaining thoracic access., ,THORACOPORT™ devices are trocars used to gain access to the thoracic cavity for use in video assis...
Medicine Products: